UNLABELLED: The aim of this study was to clarify whether common single nucleotide polymorphisms (SNPs) of the Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) gene (rs1801282) and the Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 (PGC-1α) gene (rs8192673) are associated with obesity indexes (BMI, waist circumference) in subjects with type 2 diabetes mellitus (T2DM) in Caucasian population. The second aim was to find an association of both polymorphisms with T2DM. METHODS: Two exonic SNPs of both genes rs1801282 of the PPAR-γ gene and rs8192673 of the PGC-1α gene) were genotyped in 881 unrelated Slovene subjects (Caucasians) with T2DM and in 348 subjects without T2DM (control subjects). RESULTS: Female homozygotes with the CC genotype of the rs8192673 had higher waist circumference in comparison with subjects with other genotypes. Homozygotes (females, males) with wild allele (Pro) of the rs1801282 (Pro12Ala polymorphism) had higher waist circumference in comparison with subjects with other genotypes. In the study, there were no differences in the distributions of the rs8192673 and the rs1801282 genotypes between patients with T2DM and controls. Linear regression analyses for both polymorphisms were performed and demonstrated an independent effect of the rs1801282 of the PPAR-γ on waist circumference in subjects with T2DM, whereas an independent effect on waist circumference was not demonstrated for the rs8192673 of the PGC-1α gene. CONCLUSIONS: In a large sample of the Caucasians the rs8192673 of the PGC-1α gene and the rs1801282 of the PPAR-γ gene were associated with waist circumference in subjects with T2DM.

2nd Department of Internal Medicine University Hospital and Comenius University Bratislava Slovak Republic

Department of Cardiovascular Diseases International Clinical Research Center St Anne's University Hospital and Masaryk University Brno Czech Republic

Department of Psychology The University of Texas Austin TX USA

Institute of Histology and Embryology Faculty of Medicine University of Ljubljana Ljubljana Slovenia

University of Texas Imaging Research Center Austin TX USA

Zobrazit více v PubMed

American Diabetes Association Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2012;35(Suppl. 1):S64–S71. doi: 10.2337/dc12-s064. PubMed DOI PMC

Du Y, Heidemann C, Gößwald A, Schmich P, Scheidt-Nave C. Prevalence and comorbidity of diabetes mellitus among non-institutionalized older adults in Germany - results of the national telephone health interview survey 'German Health Update (GEDA)' 2009. BMC Public Health. 2013;13:166. doi: 10.1186/1471-2458-13-166. PubMed DOI PMC

Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4–14. doi: 10.1016/j.diabres.2009.10.007. PubMed DOI

Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–321. doi: 10.1016/j.diabres.2011.10.029. PubMed DOI

Shigemizu D, Abe T, Morizono T, Johnson TA, Boroevich KA, Hirakawa Y, et al. The Construction of Risk Prediction Models Using GWAS Data and Its Application to a Type 2 Diabetes Prospective Cohort. PLoS One. 2014;9(3):e92549. doi: 10.1371/journal.pone.0092549. PubMed DOI PMC

Xi B, Takeuchi F, Meirhaeghe A, Kato N, Chambers JC, Morris AP, et al. Associations of genetic variants in/near body mass index-associated genes with type 2 diabetes: a systematic meta-analysis. Clin Endocrinol (Oxf). 2014 Feb 16. doi:10.1111/cen.12428. PubMed PMC

Klemenc-Ketis Z, Peterlin B. Family history as a predictor for disease risk in healthy individuals: a cross-sectional study in Slovenia. PLoS One. 2013;8(11) doi: 10.1371/journal.pone.0080333. PubMed DOI PMC

Deeb SS, Brunzell JD. The role of the PGC1α Gly482Ser polymorphism in weight gain due to intensive diabetes therapy. PPAR Res. 2009;2009:649286. doi: 10.1155/2009/649286. PubMed DOI PMC

Petrovic MG, Kunej T, Peterlin B, Dovc P, Petrovic D. Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of the PPARgamma gene is not. Diabetes Metab Res Rev. 2005;21(5):470–4. doi: 10.1002/dmrr.546. PubMed DOI

Maver A, Hristovski D, Rindflesch TC, Peterlin B. Integration of data from omic studies with the literature-based discovery towards identification of novel treatments for neovascularization in diabetic retinopathy. Biomed Res Int. 2013;2013:848952. doi: 10.1155/2013/848952. PubMed DOI PMC

Soyal S, Krempler F, Oberkofler H, Patsch W. PGC-1alpha: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes. Diabetologia. 2006;49(7):1477–88. doi: 10.1007/s00125-006-0268-6. PubMed DOI

Habek JC, Lakusic N, Kruzliak P, Sikic J, Mahovic D, Vrbanic L. Left ventricular diastolic function in diabetes mellitus type 2 patients: correlation with heart rate and its variability. Acta Diabetol. 2014;51:999–1005. doi: 10.1007/s00592-014-0658-z. PubMed DOI

Sharma S, Saxena S, Srivastav K, Shukla R, Mishra N, Meyer CH, et al. Nitric oxide and oxidative stress is associated with severity of diabetic retinopathy and retinal structural alterations. Clin Experiment Ophthalmol. 2015 PubMed

Bendzala M, Kruzliak P, Gaspar L, Soucek M, Mrdovic I, Sabaka P, et al. Prognostic significance of dipping in older hypertensive patients. Blood Press. 2015;24:103–10. doi: 10.3109/08037051.2014.992198. PubMed DOI

O’Rahilly S, Barroso I, Wareham NJ. Genetic factors in type 2 diabetes: the end of the beginning? Science. 2005;307:370–373. doi: 10.1126/science.1104346. PubMed DOI

Barroso I, Luan J, Middelberg RP, Harding AH, Franks PW, Jakes RW, et al. Candidate gene association study in type 2 diabetes indicates a role for genes involved in β-cell function as well as insulin action. PLoS Biol. 2003;1:41–55. doi: 10.1371/journal.pbio.0000020. PubMed DOI PMC

Pratley RE, Thompson DB, Prochazka M, Baier L, Mott D, Ravussin E, et al. An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest. 1998;101:1757–1764. doi: 10.1172/JCI1850. PubMed DOI PMC

Ek J, Andersen G, Urhammer SA, Gaede PH, Drivsholm T, Borch-Johnsen K, et al. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia. 2001;44(12):2220–6. doi: 10.1007/s001250100032. PubMed DOI

Andersen G, Hansen T, Gharani N, Frayling TM, Owen KR, Sampson M, et al. A common Gly482Sser polymorphism of PGC-1 is associated with type 2 diabetes mellitus in two European populatins (Abstract) Diabetes. 2002;51(suppl 2):A49.

Lacquemant C, Chikri M, Boutin P, Samson C, Froguel P. No association between the G482S polymorphism of the proliferator-activated receptor-γ coactivator-1 gene and Type II diabetes in French Caucasias. Diabetologia. 2002;45:602–603. doi: 10.1007/s00125-002-0783-z. PubMed DOI

Hara K, Tobe K, Okada T, Kadowaki H, Akanuma Y, Ito C, et al. A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes. Diabetologia. 2002;45:740–743. doi: 10.1007/s00125-002-0803-z. PubMed DOI

Muller YL, Bogardus C, Beamer BA, Shuldiner AR, Baier LJ. A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians. Diabetes. 2003;52(7):1864–71. doi: 10.2337/diabetes.52.7.1864. PubMed DOI

Muller YL, Bogardus C, Pedersen O, Baier L. A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor-γ coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians. Diabetes. 2003;52:895–898. doi: 10.2337/diabetes.52.3.895. PubMed DOI

Esterbauer H, Oberkofler H, Linnemayr V, Iglseder B, Hedegger M, Wolfsgruber P, et al. Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: associations with obesity indices in middle-aged women. Diabetes. 2002;51(4):1281–6. doi: 10.2337/diabetes.51.4.1281. PubMed DOI

Parikh H, Groop L. Candidate genes for type 2 diabetes. Rev Endocr Metab Disord. 2004;5:151–176. doi: 10.1023/B:REMD.0000021437.46773.26. PubMed DOI

Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79(3):379–84. PubMed

Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G. et al;  European Society of Hypertension ;  European Society of Cardiology . 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Blood Press. 2007;16:135–232. doi: 10.1080/08037050701461084. PubMed DOI

Kunej T, Globocnik Petrovic M, Dovc P, Peterlin B, Petrovic D. A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians. Folia Biol (Praha) 2004;50(5):157–8. PubMed

Meshkani R, Taghikhani M, Larijani B, Bahrami Y, Khatami S, Khoshbin E, et al. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population. Clin Chem Lab Med. 2007;45(4):477–82. doi: 10.1515/CCLM.2007.095. PubMed DOI

Cordell HJ. Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet. 2009;10:392–404. doi: 10.1038/nrg2579. PubMed DOI PMC

Pan W, Basu S, Shen X. Adaptive tests for detecting gene-gene and gene- environment interactions. Hum Hered. 2011;72:98–109. doi: 10.1159/000330632. PubMed DOI PMC

Marcadenti A, Fuchs FD, Matte U, Sperb F, Moreira LB, Fuchs SC. Effects of FTO RS9939906 and MC4R RS17782313 on obesity, type 2 diabetes mellitus and blood pressure in patients with hypertension. Cardiovasc Diabetol. 2013;12:103. doi: 10.1186/1475-2840-12-103. PubMed DOI PMC

Gragnoli C. Overweight condition and waist circumference and a candidate gene within the 12q24 locus. Cardiovasc Diabetol. 2013;12:2. doi: 10.1186/1475-2840-12-2. PubMed DOI PMC

Gu Q, Yazdanpanah M, van Hoek M, Hofman A, Gao X, de Rooij FW, et al. Common variants in PCSK1 influence blood pressure and body mass index. J Hum Hypertens. 2015;29(2):82–86. doi: 10.1038/jhh.2014.59. PubMed DOI

Corella D, Sorlí JV, González JI, Ortega C, Fitó M, Bulló M, et al. Novel association of the obesity risk-allele near Fas Apoptotic Inhibitory Molecule 2 (FAIM2) gene with heart rate and study of its effects on myocardial infarction in diabetic participants of the PREDIMED trial. Cardiovasc Diabetol. 2014;13:5. doi: 10.1186/1475-2840-13-5. PubMed DOI PMC

Ghanbari M, Sedaghat S, de Looper HW, Hofman A, Erkeland SJ, Franco OH, et al. The association of common polymorphisms in miR-196a2 with waist to hip ratio and miR-1908 with serum lipid and glucose. Obesity (Silver Spring) 2015;23(2):495–503. doi: 10.1002/oby.20975. PubMed DOI

Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889–893. doi: 10.1126/science.1141634. PubMed DOI PMC

Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshift mutation in MC4R is associated with a dominant form of obesity. Nature Genet. 1998;20:113–114. doi: 10.1038/2407. PubMed DOI

Thomas MKYK, Tenser MS, Wong GG, Habener JF. Bridge-1, a novel PDZ- domain coactivator of E2A-mediated regulation of insulin gene transcription. Mol Cell Biol. 1999;19:8492. PubMed PMC

Volinic JL, Lee JH, Eto K, Kaur V, Thomas MK. Overexpression of the coactivator bridge-1 results in insulin deficiency and diabetes. Mol Endocrinol. 2006;20:167. doi: 10.1210/me.2005-0127. PubMed DOI